2019\u5e747\u670824\u65e5<\/p>\n
Veeva Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
<\/p>\n
\u81e8\u5e8a\u958b\u767a\u696d\u52d9\u306e\u30d7\u30ed\u30d5\u30a7\u30c3\u30b7\u30e7\u30ca\u30eb\u3092\u5bfe\u8c61\u3068\u3057\u305f\u904e\u53bb\u6700\u5927\u898f\u6a21\u306e\u8abf\u67fb\u3067\u3042\u308bVeeva 2019 Unified Clinical Operations Survey<\/a><\/strong>\u306e\u7d50\u679c\u3001\u73fe\u5728\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u5168\u4f53\u3067\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u53ef\u8996\u6027\u3068\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u5411\u4e0a\u3055\u305b\u308b\u305f\u3081\u306b\u3001\u8a66\u9a13\u306e\u30d7\u30ed\u30bb\u30b9\u3068\u30b7\u30b9\u30c6\u30e0\u306e\u52b9\u7387\u5316\u304c\u63a8\u3057\u9032\u3081\u3089\u308c\u3066\u3044\u308b\u3053\u3068\u304c\u660e\u3089\u304b\u306b\u306a\u308a\u307e\u3057\u305f\u3002<\/p>\n Veeva Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b Veeva) \u304c\u65b0\u305f\u306b\u5b9f\u65bd\u3057\u305f\u8abf\u67fb\u306b\u3088\u308b\u3068\u3001\u5bfe\u8c61\u3068\u306a\u3063\u305f\u56de\u7b54\u8005\u306e\u5168\u54e1\uff08100%\uff09\u304c\u3001\u81e8\u5e8a\u8a66\u9a13\u30d1\u30fc\u30c8\u30ca\u30fc\u9593\u306e\u60c5\u5831\u4ea4\u63db\u306e\u6539\u5584\u304c\u5fc5\u8981\u3060\u3068\u56de\u7b54\u3057\u3066\u3044\u307e\u3059\u3002\u56de\u7b54\u8005\u306f\u3001\u30b9\u30dd\u30f3\u30b5\u30fc\u3001CRO\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306e\u9593\u3067\u306e\u81e8\u5e8a\u8a66\u9a13\u30c7\u30fc\u30bf\u3084\u6587\u66f8\u306e\u5171\u6709\u306b\u5e73\u5747\u3057\u3066\u5c11\u306a\u304f\u3068\u30823\u7a2e\u985e\u306e\u65b9\u6cd5\u3092\u7528\u3044\u3066\u304a\u308a\u3001\u96fb\u5b50\u30e1\u30fc\u30eb\u3092\u6700\u3082\u591a\u304f\u4f7f\u7528\u3057\u3066\u3044\u307e\u3059\u3002\u5927\u534a\u306e\u56de\u7b54\u8005\u306f\u3001\u60c5\u5831\u4ea4\u63db\u306e\u52b9\u7387\u5316\u306b\u5411\u304b\u3063\u3066\u3044\u308b\u52d5\u304d\u306e\u4fc3\u9032\u8981\u56e0\u3068\u3057\u3066\u3001\u81e8\u5e8a\u8a66\u9a13\u671f\u9593\u306b\u304a\u3051\u308b\u624b\u4f5c\u696d\u306e\u30d7\u30ed\u30bb\u30b9\u306e\u524a\u6e1b\uff0871%\uff09\u3001\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u306e\u6539\u5584\uff0866%\uff09\u3001\u53ef\u8996\u6027\u3068\u30aa\u30fc\u30d0\u30fc\u30b5\u30a4\u30c8\u306e\u5411\u4e0a\uff0864%\uff09\u306e\u5fc5\u8981\u6027\u3092\u6319\u3052\u3066\u3044\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001Veeva\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f\u3053\u3061\u3089<\/a><\/strong>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n <\/p>\n \u307e\u305f\u3001\u307b\u307c\u3059\u3079\u3066\u306e\u30b9\u30dd\u30f3\u30b5\u30fc\u3068CRO\uff0899%\uff09\u304c\u3001\u53ef\u8996\u6027\u306e\u5411\u4e0a\uff0870%\uff09\u3068\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u306e\u5bb9\u6613\u5316\uff0861%\uff09\u3092\u5b9f\u73fe\u3059\u308b\u306b\u306f\u3001\u81e8\u5e8a\u696d\u52d9\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306e\u7d71\u5408\u5316\u304c\u5fc5\u8981\u3060\u3068\u3057\u3066\u3044\u307e\u3059\u3002\u81e8\u5e8a\u8a66\u9a13\u306e\u7ba1\u7406\u306b\u95a2\u3059\u308b\u8ab2\u984c\u306e\u591a\u304f\u306f\u3001\u30b5\u30a4\u30ed\u5316\u3057\u305f\u30d7\u30ed\u30bb\u30b9\u3084\u30b7\u30b9\u30c6\u30e0\u304c\u539f\u56e0\u3068\u306a\u3063\u3066\u304a\u308a\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u9032\u6357\u72b6\u6cc1\u3092\u5b8c\u5168\u306b\u628a\u63e1\u3059\u308b\u306e\u3092\u59a8\u3052\u3001\u8a66\u9a13\u306e\u5b9f\u65bd\u3092\u9045\u3089\u305b\u307e\u3059\u3002\u56de\u7b54\u8005\u304c\u3001\u7d71\u5408\u5316\uff0868%\uff09\u3068\u30ec\u30dd\u30fc\u30c6\u30a3\u30f3\u30b0\uff0857%\uff09\u3092\u4e0a\u4f4d2\u3064\u306e\u554f\u984c\u70b9\u306b\u6319\u3052\u305f\u3053\u3068\u306f\u3001\u81e8\u5e8a\u958b\u767a\u30b7\u30b9\u30c6\u30e0\u306e\u30b5\u30a4\u30ed\u5316\u306b\u3088\u308b\u5fc5\u7136\u7684\u306a\u7d50\u679c\u3068\u8a00\u3048\u307e\u3059\u3002<\/p>\n \u81e8\u5e8a\u8a66\u9a13\u306e\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u3092\u6539\u5584\u3057\u3066\u8a66\u9a13\u306e\u5b9f\u65bd\u3092\u8fc5\u901f\u5316<\/strong><\/p>\n \u81e8\u5e8a\u8a66\u9a13\u306e\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u52b9\u7387\u5316\u3068\u8fc5\u901f\u5316\u3092\u6700\u3082\u671f\u5f85\u3067\u304d\u308b\u81e8\u5e8a\u958b\u767a\u5206\u91ce\u306e1\u3064\u3067\u3059\u3002\u56de\u7b54\u8005\u306e\u5168\u54e1\u304c\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u306b\u95a2\u3057\u3066\u6df1\u523b\u306a\u8ab2\u984c\u3092\u62b1\u3048\u3066\u3044\u308b\u3068\u56de\u7b54\u3057\u3066\u3044\u307e\u3059\u304c\u3001\u3053\u308c\u306f\u304a\u305d\u3089\u304f\u624b\u4f5c\u696d\u306e\u30d7\u30ed\u30bb\u30b9\u306b\u5927\u304d\u304f\u4f9d\u5b58\u3057\u3066\u3044\u308b\u305f\u3081\u3067\u3042\u308b\u3068\u8003\u3048\u3089\u308c\u307e\u3059\u3002\u5927\u90e8\u5206\u306e\u56de\u7b54\u8005\uff0881%\uff09\u306f\u3001\u3053\u306e\u696d\u52d9\u9818\u57df\u306e\u7ba1\u7406\u306b\u30b9\u30d7\u30ec\u30c3\u30c9\u30b7\u30fc\u30c8\u3092\u4f7f\u7528\u3057\u3066\u3044\u308b\u304b\u3089\u3067\u3059\u3002<\/p>\n \u30b5\u30a4\u30af\u30eb\u30bf\u30a4\u30e0\u3092\u65e9\u3081\u308b\u305f\u3081\u306b\u5c02\u7528\u306eStudy Start-up\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u5c0e\u5165\u3059\u308b\u30b9\u30dd\u30f3\u30b5\u30fc\u3084CRO\u306f\u3001\u307e\u3059\u307e\u3059\u5897\u3048\u3066\u3044\u307e\u3059\u3002\u73fe\u5728\u3067\u306f\u56de\u7b54\u8005\u306e4\u5206\u306e1\u8fd1\u304f\uff0823%\uff09\u304c\u3001\u5c02\u7528\u306eStudy Start-up\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u4f7f\u7528\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n \u8abf\u67fb\u306b\u3088\u308b\u3068\u5927\u90e8\u5206\u306e\u56de\u7b54\u8005\u304c\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u306b\u8981\u3059\u308b\u671f\u9593\u306e\u77ed\u7e2e\uff0871%\uff09\u3092\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u30d7\u30ed\u30bb\u30b9\u306e\u6539\u5584\u306b\u304a\u3051\u308b\u4e3b\u306a\u4fc3\u9032\u8981\u56e0\u3068\u3057\u3066\u6319\u3052\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u56de\u7b54\u8005\u306e\u534a\u6570\uff0850%\uff09\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u30b9\u30bf\u30fc\u30c8\u30a2\u30c3\u30d7\u671f\u9593\u306b\u304a\u3051\u308b\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u306e\u5f37\u5316\u304c\u3001\u6539\u5584\u3059\u3079\u304d\u9818\u57df\u3067\u3042\u308b\u3068\u3057\u3066\u3044\u308b\u3053\u3068\u304b\u3089\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u52b9\u7387\u3068\u30b9\u30d4\u30fc\u30c9\u306e\u5411\u4e0a\u306b\u306f\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u304c\u91cd\u8981\u3067\u3042\u308b\u3053\u3068\u304c\u6d6e\u304d\u5f6b\u308a\u306b\u306a\u308a\u307e\u3057\u305f\u3002<\/p>\n \u5148\u9032\u7684\u306a\u81e8\u5e8a\u8a66\u9a13\u696d\u52d9\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306e\u7740\u5b9f\u306a\u5c0e\u5165<\/strong><\/p>\n \u3053\u3053\u6570\u5e74\u3092\u304b\u3051\u3066\u3001\u30b9\u30dd\u30f3\u30b5\u30fc\u3068CRO\u306f\u5c02\u7528\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306e\u5c0e\u5165\u3092\u7740\u5b9f\u306b\u9032\u3081\u3001\u81e8\u5e8a\u8a66\u9a13\u5b9f\u65bd\u306e\u6539\u5584\u3092\u56f3\u3063\u3066\u304d\u307e\u3057\u305f\u3002\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306feTMF\u306a\u3069\u306e\u4e3b\u8981\u306a\u81e8\u5e8a\u958b\u767a\u9818\u57df\u306b\u304a\u3051\u308b\u30d7\u30ed\u30bb\u30b9\u3068\u30b7\u30b9\u30c6\u30e0\u3092\u6700\u65b0\u5316\u3057\u3066\u304a\u308a\u3001\u305d\u306e\u6069\u6075\u3092\u5b9f\u611f\u3057\u3066\u3044\u307e\u3059\u3002\u4e00\u65b9\u3067\u30b9\u30dd\u30f3\u30b5\u30fc\u3068CRO\u306f\u3001CTMS\u306a\u3069\u4ed6\u306e\u9818\u57df\u306b\u304a\u3044\u3066\u3001\u30ec\u30ac\u30b7\u30fc\u30b7\u30b9\u30c6\u30e0\u304c\u5e83\u304f\u4f7f\u308f\u308c\u3066\u3044\u308b\u3053\u3068\u306b\u3088\u308b\u8ab2\u984c\u304c\u5b58\u5728\u3059\u308b\u3068\u56de\u7b54\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n \u307b\u307c\u3059\u3079\u3066\u306e\u56de\u7b54\u8005\uff0895%\uff09\u306f\u3001\u81e8\u5e8a\u958b\u767a\u696d\u52d9\u306b\u304a\u3051\u308bCTMS\u306e\u4f7f\u7528\u6539\u5584\u304c\u5fc5\u8981\u3060\u3068\u3057\u3066\u3044\u307e\u3059\u3002\u305d\u306e\u4e3b\u306a\u7406\u7531\u3068\u3057\u3066\u5927\u534a\u306e\u56de\u7b54\u8005\u304c\u6319\u3052\u3066\u3044\u308b\u306e\u306f\u3001\u5206\u6790\u3068\u30ec\u30dd\u30fc\u30c6\u30a3\u30f3\u30b0\u306e\u6539\u5584\uff0868%\uff09\u3068\u53ef\u8996\u6027\u306e\u5411\u4e0a\uff0860%\uff09\u3067\u3059\u3002\u307e\u305f\u3001\u30b9\u30dd\u30f3\u30b5\u30fc\u3068CRO\u306e\u304a\u3088\u305d\u534a\u6570\uff0848%\uff09\u306f\u3001\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u306e\u5bb9\u6613\u5316\u3092\u4e3b\u306a\u4fc3\u9032\u8981\u56e0\u3068\u3057\u3066\u6319\u3052\u3066\u304a\u308a\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u5b9f\u65bd\u671f\u9593\u4e2d\u306e\u30b3\u30df\u30e5\u30cb\u30b1\u30fc\u30b7\u30e7\u30f3\u3068\u60c5\u5831\u5171\u6709\u306e\u52b9\u7387\u5316\u3092\u91cd\u8996\u3057\u3066\u3044\u308b\u3053\u3068\u304c\u660e\u3089\u304b\u3068\u306a\u308a\u307e\u3057\u305f\u3002<\/p>\n eTMF\u5c02\u7528\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u4f7f\u7528\u3057\u3066\u3044\u308b\u56de\u7b54\u8005\u306e\u6570\u306f\u30012014\u5e74\u304b\u30893\u500d\u306b\u5897\u3048\u3066\u3044\u307e\u3059\u304c\u3001\u305d\u306e\u4e00\u65b9\u3067\u3001\u6c4e\u7528\u7684\u624b\u6cd5\u3067 TMF\u30d7\u30ed\u30bb\u30b9\u3092\u7ba1\u7406\u3057\u3066\u3044\u308b\u56de\u7b54\u8005\u306f\u6e1b\u5c11\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306e\u7d42\u4e86\u6642\u306b\u6587\u66f8\u306e\u4fdd\u5b58\u3068\u30a2\u30fc\u30ab\u30a4\u30d6\u3092\u884c\u3046\u305f\u3081\u306e\u9759\u7684\u30ea\u30dd\u30b8\u30c8\u30ea\u3068\u3057\u3066\u6a5f\u80fd\u3059\u308bTMF\u30b7\u30b9\u30c6\u30e0\u304b\u3089\u3001\u7a4d\u6975\u578b\u2018active\u2019\u81e8\u5e8a\u8a66\u9a13\u7ba1\u7406\u3092\u5b9f\u73fe\u3059\u308b\u6700\u65b0\u306eeTMF\u5c02\u7528\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3078\u306e\u79fb\u884c\u304c\u7d9a\u3044\u3066\u3044\u308b\u3053\u3068\u3092\u793a\u5506\u3057\u3066\u3044\u307e\u3059\u3002eTMF\u5c02\u7528\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3092\u4f7f\u7528\u3057\u3066\u3044\u308b\u56de\u7b54\u8005\u306f\u3001\u67fb\u5bdf\u6e96\u5099\u4f53\u5236\u306e\u7dad\u6301\uff0860%\uff09\u3084TMF\u30b9\u30c6\u30fc\u30bf\u30b9\u306b\u5bfe\u3059\u308b\u53ef\u8996\u6027\uff0858%\uff09\u306b\u95a2\u3059\u308b\u80fd\u529b\u304c\u5411\u4e0a\u3057\u305f\u3068\u56de\u7b54\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n Vault Clinical\u62c5\u5f53\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3067\u3042\u308bJim Reilly\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u81e8\u5e8a\u8a66\u9a13\u306e\u53ef\u8996\u6027\u3068\u81e8\u5e8a\u8a66\u9a13\u30d1\u30fc\u30c8\u30ca\u30fc\u9593\u306e\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u6539\u5584\u3057\u3066\u3001\u8a66\u9a13\u306e\u5b9f\u65bd\u3092\u8fc5\u901f\u5316\u3059\u308b\u305f\u3081\u306e\u3001\u5927\u304d\u306a\u30c1\u30e3\u30f3\u30b9\u304c\u696d\u754c\u5168\u4f53\u306b\u3082\u305f\u3089\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u81e8\u5e8a\u8a66\u9a13\u306e\u30d7\u30ed\u30bb\u30b9\u304a\u3088\u3073\u30b7\u30b9\u30c6\u30e0\u306e\u30b9\u30ea\u30e0\u5316\u3092\u91cd\u8996\u3059\u308b\u30b9\u30dd\u30f3\u30b5\u30fc\u3001CRO\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u304c\u5897\u3048\u3066\u3044\u308b\u305f\u3081\u3001\u533b\u85ac\u54c1\u306e\u958b\u767a\u306f\u307e\u3059\u307e\u3059\u52b9\u7387\u5316\u3055\u308c\u3001\u81e8\u5e8a\u8a66\u9a13\u30e9\u30a4\u30d5\u30b5\u30a4\u30af\u30eb\u5168\u4f53\u306b\u304a\u3051\u308b\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u540c\u58eb\u306e\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u3082\u5f37\u5316\u3055\u308c\u308b\u3067\u3057\u3087\u3046\u3002\u300d<\/p>\n Veeva 2019 Unified Clinical Operations Survey<\/em><\/a><\/strong>\u3067\u306f\u3001\u81e8\u5e8a\u958b\u767a\u74b0\u5883\u306e\u7d71\u5408\u5316\u306b\u5411\u304b\u3046\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306e\u52d5\u5411\u3092\u8abf\u67fb\u3057\u3001\u4e16\u754c\u5404\u5730\u304b\u3089461\u4eba\u306e\u81e8\u5e8a\u958b\u767a\u696d\u52d9\u306e\u30d7\u30ed\u30d5\u30a7\u30c3\u30b7\u30e7\u30ca\u30eb\u306e\u7d4c\u9a13\u8ac7\u3068\u610f\u898b\u3092\u96c6\u3081\u307e\u3057\u305f\u3002\u672c\u8abf\u67fb\u3067\u306f\u3001\u7d71\u5408\u5316\u3055\u308c\u305f\u81e8\u5e8a\u958b\u767a\u696d\u52d9\u30e2\u30c7\u30eb\u306e\u4fc3\u9032\u8981\u56e0\u3001\u969c\u58c1\u3001\u30e1\u30ea\u30c3\u30c8\u3092\u8abf\u67fb\u3057\u3001\u81e8\u5e8a\u958b\u767a\u30b7\u30b9\u30c6\u30e0\u3068\u696d\u52d9\u30d7\u30ed\u30bb\u30b9\u3092\u7d71\u5408\u5316\u3057\u3066\u8a66\u9a13\u5b9f\u65bd\u30d7\u30ed\u30bb\u30b9\u5168\u4f53\u3067\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u9593\u306e\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u9032\u3081\u3066\u3044\u308b\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306e\u52d5\u5411\u3092\u8abf\u67fb\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n <\/p>\n \u3010Veeva Systems\u793e\u306b\u3064\u3044\u3066\u3011<\/strong> \u3010Forward-looking Statements\u3011<\/strong> 2019\u5e747\u670824\u65e5 Veeva Japan\u682a\u5f0f\u4f1a\u793e \u81e8\u5e8a\u958b\u767a\u696d\u52d9\u306e\u30d7\u30ed\u30d5\u30a7\u30c3\u30b7\u30e7\u30ca\u30eb\u3092\u5bfe\u8c61\u3068\u3057\u305f\u904e\u53bb\u6700\u5927\u898f\u6a21\u306e\u8abf\u67fb\u3067\u3042\u308bVeeva 2019 Unified Clinical Operations Sur…<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-42791","post","type-post","status-publish","format-standard","hentry","category-press-release","category-case-study"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42791"}],"collection":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=42791"}],"version-history":[{"count":3,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42791\/revisions"}],"predecessor-version":[{"id":42794,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42791\/revisions\/42794"}],"wp:attachment":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=42791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=42791"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=42791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nVeeva Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u3084\u305d\u306e\u4ed6\u306e\u898f\u5236\u3092\u53d7\u3051\u308b\u88fd\u9020\u696d\u8005\u5411\u3051\u306b\u3001\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067750\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002Veeva\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of Veeva\u2019s products and services, the results from use of Veeva\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-K for the period ended April 30, 2019. This is available on the company\u2019s website at www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"